Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Gene Discovery Provides Clue to How TB May Evade the Immune System

March 17, 2015 9:01 am | by University of Cambridge | News | Comments

The largest genetic study of tuberculosis susceptibility to date has led to a potentially important new insight into how the pathogen manages to evade the immune system. Read more...

TOPICS:

New System Made for Detecting Adverse Effects of Medications Using Social Media

March 17, 2015 8:55 am | by Universidad Carlos III de Madrid | News | Comments

Researchers have developed a system for detecting adverse effects of pharmaceutical drugs by tracking information generated by patients on specialized blogs or social networks such as Twitter in real time. Read more...

TOPICS:

GSK Announces Start of Phase 3 Program for Retosiban Evaluation

March 17, 2015 8:46 am | News | Comments

Retosiban is an investigational oxytocin antagonist. Read more...

TOPICS:
Advertisement

American Who Contracted Ebola Now in Critical Condition

March 17, 2015 8:41 am | by Brett Zongker, Associated Press | News | Comments

An American health care worker who contracted Ebola while volunteering in a Sierra Leone treatment unit has been downgraded to critical condition at the National Institutes of Health, doctors said Monday. Read more...

TOPICS:

Scientists Make Surprise Finding in Stroke Research

March 17, 2015 8:37 am | by University of Manchester | News | Comments

Scientists have made an important new discovery about the brain’s immune system that could lead to potential new treatments for stroke and other related conditions. Read more...

TOPICS:

UK, Drugmakers Establish $100M Alzheimer's Venture Fund

March 17, 2015 8:32 am | by Linda A. Johnson, AP Business Writer | News | Comments

Major drugmakers, the British government and a top Alzheimer's research charity are pooling more than $100 million to create a global fund to accelerate efforts to find a treatment or even a cure for the mind-robbing disease within a decade. Read more...

TOPICS:

Sickle Cell Drug Offers “Overwhelming” Gains as “Exciting” Stem Cell Trial Starts

March 16, 2015 3:58 pm | by Cynthia Fox, Science Editor | Articles | Comments

A clinical trial of the most common sickle cell anemia drug, hydroxyurea, was halted a year early this winter because of “overwhelming evidence of benefit,” reported University of Nebraska Medical Center pediatric researcher Stephen Obaro, M.D., Ph.D., in The Lancet. Read more...

TOPICS:

Researchers Unlock the Mysteries of Wound Healing

March 16, 2015 11:49 am | by Jill Goetz, UA News | News | Comments

A multidisciplinary research team discovers how cells know to rush to a wound and heal it – opening the door to new treatments for diabetes, heart disease and cancer. Researchers at the University of Arizona have discovered what causes and regulates collective cell migration, one of the most universal but least understood biological processes in all living organisms. Read more...

TOPICS:
Advertisement

Oncologists Share Reasons for Cancer Drugs' High Cost, Recommend Solutions

March 16, 2015 11:18 am | News | Comments

Increasingly high prices for cancer drugs are affecting patient care in the U.S. and the American health care system overall, say the authors of a special article published online in the journal Mayo Clinic Proceedings. Read more...

TOPICS:

Cidara Therapeutics Files for IPO

March 16, 2015 11:18 am | by Ryan Bushey, Associate Editor | News | Comments

The biotech firm based in San Diego is only two years old. Read more...

TOPICS:

New Sign-Up Under Health Care Law Gets Lukewarm Reception

March 16, 2015 10:50 am | by Ricardo Alonso-Zaldivar, Associated Press Writer | News | Comments

Several million people hit with new federal fines for going without health insurance are getting a second chance to sign up, and that could ease the sting of rising penalties for being uninsured. Read more....

TOPICS:

Amgen's Cholesterol-Lowering Repatha Shows Positive Data

March 16, 2015 10:19 am | News | Comments

Amgen announced new detailed data from the Phase 3 YUKAWA-2 study evaluating Repatha (evolocumab), a novel investigational cholesterol-lowering medication, in Japanese patients with high cardiovascular risk and high cholesterol.  Read more...

TOPICS:

Studies Boost Hopes for New Class of Cholesterol Drugs

March 16, 2015 10:00 am | by Marilynn Marchione, AP Chief Medical Writer - Associated Press | News | Comments

New research boosts hope that a highly anticipated, experimental class of cholesterol drugs can greatly lower the risk for heart attacks, death and other heart-related problems. The government will decide this summer whether to allow two of these drugs on the market. Read more...

TOPICS:

Valeant, Salix Agree on Amended Terms for Merger Agreement

March 16, 2015 8:40 am | News | Comments

Valeant and Salix Pharmaceuticals announce an amended agreement for its anticipated merger. Read more...

TOPICS:

German Court Orders Vaccination Cynic to Pay for Virus Proof

March 16, 2015 8:35 am | by The Associated Press | News | Comments

A German court has ruled that a prominent anti-vaccination advocate must pay a doctor 100,000 euros ($105,720) in prize money he had promised to anyone who could prove measles is a virus. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading